Exelixis (NASDAQ:EXEL) Comes up with Positive Results for its Study of Phase 3 of Cobimetinib Drug
Exelixis, Inc. (NASDAQ:EXEL) is a biopharma company that is committed to the development and commercialization…
Author Chris Hillman
Chris Hillman
Expert on stocks. Currently working at Stocks.
Barclays gives Apple a rating of Overweight, with a target price of $110
Barclays recently released its research report, covering Apple Inc. (NASDAQ:AAPL)’s shares. Analysts at Barclays changed…
Hot Stocks in Communication Equipment Industry: Aerohive Networks Inc. (NYSE:HIVE), DragonWave (NASDAQ:DRWI), InfoSonics Corporation (NASDAQ:IFON), Barracuda Networks Inc. (NYSE:CUDA), Turtle Beach Corp (NASDAQ:HEAR)
Aerohive Networks Inc. (NYSE:HIVE)’s compensation committee ran its tests and conducted its research on the…
Cummins (NYSE:CMI) ETHOS 2.8L Reduces the CO2 Emissions by 50% to 80% – Trials Being Held on the Roads of Sacramento, California
Cummins Inc. CMI, on July 14, announced that it will develop a new powertrain and engine,…
Biotech Stocks Updates: Ariad Pharmaceuticals (NASDAQ:ARIA), Gilead Sciences (NASDAQ:GILD), Celgene Corporation (NASDAQ:CELG), Arena Pharmaceuticals (NASDAQ:ARNA)
Twenty-three market research firms that were covering Ariad Pharmaceuticals (NASDAQ:ARIA) stocks gave the stocks a…
BioTech Stocks to Watch: Arrowhead Research (NASDAQ:ARWR) Is on Road to Recovery
Arrowhead Research (NASDAQ:ARWR) has been identified as the “dead cat bounce” nominee by Trade-Ideas LLC. This…